Product Innovation

Week One - July 26-30

Custom Content Solutions: Learning Labs

Do you have a product, solution or technology to showcase to the CPhI audience?

Week two of our digital content program is dedicated to celebrating innovation across biologics, manufacturing technologies, outsourcing, drug development and formulation, packaging and drug delivery solutions.

Choose the focus of your session and your speaker, and we'll work with you to record a mini webinar that will form part of the digital agenda.

20-minute session
You choose the topic and speaker
Designed to be product and solution led
Perfect for product demos
All content pre-recorded and available on-demand

Week One - July 26-30

Innovation in Pharma Ingredients

Unlocking the Power and Versatility of Plant-Based Softgels

On-Demand from July 27

While plant-based diets continue to grow in popularity, the desire to live and act more sustainably and healthfully is on the rise. With our Vegetarian Softgel Technology, Versagel™, companies can now offer their patients and consumers Non-GMO, plant-based softgel products as an optimal solution for their latest demands without losing the versatility and benefits of regular softgel capsules.

Changing to a plant-based alternative should not affect overall product performance and quality. Versagel™ offers not only great appearance but an overall competitive edge, the cornerstone for your next big project. Join us!

Speaker:

Carolina Quintero, Director, New Platform Technologies, Softgel Procaps
Carlos Perez, Commercial & Technical Director, Softgel Technologies, Softgel Procaps

Week One- July 26-30

Innovation in Manufacturing, Tech & Equipment

Proactive Planning for Supply Chain Risk Mitigation

On-Demand from July 28

- Supply Chain Disruptions
- Misconceptions of Secondary Sourcing
- Preventative Strategies

Speaker: Scott Rizzo, MBA, MMM, Senior Vice President & General Manager, Recro

Lonza Tampa - Expansions in HPAPI for Oral Solid and Inhalation Technology

On-Demand from July 28

Our facilities in Tampa (FL) US are an integral component of Lonza’s design, development and manufacturing network for drug substances and specialized drug products. Working collaboratively with our customers, our Tampa team designs develop and manufacture oral solid and inhalation drug products. The site provides a full range of services, starting from the initial stages of product development including pre-formulation, formulation & process design, and analytical method development. These services extend into early phase clinical, late phase clinical, and commercial-scale production including packaging and distribution worldwide. Tampa also serves as our US Center of Excellence for rapid first-in-human services utilizing Powder-in-Capsule (PIC) based on our proprietary Xcelodose® Precision Powder Micro-Dosing Technology to effectively increase speed-to-clinic initiatives.

Speaker: Jeff Williamson, Director, Product Development, Lonza

Innovation in Manufacturing, Tech & Equipment

Lonza Quakertown - Micronization & Particle Size Control

On-Demand from July 28

Lonza Quakertown provides expertise in particle size reduction and classification servicing the cGMP pharmaceutical marketplace. The presentation will provide a description of the site and an overview of capabilities specific to micronization and classification while highlighting the value of particle size reduction and control. The basic mechanics of jet milling will be explored along with process development and process scale-up. The presentation will conclude with a discussion of the option of combining micronization services with other platforms and technologies within Lonza as an integrated service offer.

Speaker: Michael Bauer, Site Head Lonza Quakertown, Lonza

Week One- July 26-30

Innovation in Packaging & Drug Delivery

Take a Breath: Selecting a Device for Inhaled Product Development

On-Demand from July 29

The future commercial success of any new inhaled medicine relies in a large part on the correct combination of formulation and device technology chosen for its delivery.

This presentation will benefit any drug developer considering an inhaled programme and aims to answer the following questions:
• How are development targets and success criteria set for inhaled products?
• What are the key factors influencing inhaled delivery platform selection?
• How can phase-appropriate device selection accelerate an inhaled development programme?

Speaker: Geraldine Venthoye, Chief Scientific Officer & Executive Vice President – Product Development, Vectura

Parenteral Packaging Selection Process for Drug Delivery Devices

On-Demand from July 29

This presentation will introduce the audience to packaging components for cartridges used in drug delivery devices today and explore future trends that are emerging in the market.

Speaker: Eugene Polini, Technical Key Account Manager, Datwyler Pharma Packaging

Innovation in Packaging & Drug Delivery

ASD-HIPROS – A new platform for quick and effective formulation screening for Amorphous Solid Dispersions by Spray Drying.

On-Demand from July 29

Introduction to Hovione’s new formulation screening platform by Spray Drying
Learn about the advantages of a platform that integrates in silico computational models, formulation, analytical development
Get to know more about Hovione’s extensive expertise in Spray Drying

Who should attend:

Formulators
Scientists
Investigators and Research fellows
R&D personnel
Technical services personnel

Speaker: Nuno Espinha, MSc in Biotechnology, Marketing Analyst Specialist, Hovione

Week One- July 26-30

Innovation in Bioprocessing & Biomanufacturing

LucasPye Bio: A Top Innovative CDMO of 2020

On-Demand from July 30

Speakers: Gervan Williams, Director, Product Development and Innovation, LucasPye Bio

Week One- July 26-30